The Canadian Pharmacists Association names its Pharmacist of the YearThe 2026 award goes to a pharmacist whose career in Nova Scotia saw much progress in the province. Baxdela (delafloxacin) is a new oral/IV fluoroquinolone antibiotic in Canada Approved by Health Canada to treat adults with acute bacterial skin and skin structure infections, and community-acquired bacterial pneumonia. ACP warns pharmacists with additional prescribing authorization against cutting corners Make sure you have the correct authorizations before prescribing—and don’t try to get around them, the ACP reminds members. Which direct oral anticoagulant is the safest when treating venous thromboembolism? Trial results suggest a ‘clear choice’ between apixaban and rivaroxaban when treating pul-monary embolism or deep vein thrombosis. Can a pharmacist reject your prescription? Lawsuits and legislation in the U.S. are testing how far pharmacists can go in declining medications based on personal beliefs. Case report: Silver Most of us come into contact with the ‘pure’ metals that aren’t supposed to cause allergic reactions—but things aren’t always so simple. The 19-cent solution Don’t scrap Canada’s $250-million e-prescribing system—mandate it, argues Dr. John Holmes. Is there a case for using antibiotics instead of surgery for acute appendicitis? New guidelines, a meta-analysis and a clinical review shed light on the surgery versus nonoperative management debate. Canadian Antibiotic Treatment Guidance for managing common infections New Canadian resource is designed to help prescribers make evidence-based decisions for treating infections in primary care and to promote better antibiotic stewardship. New resource for patients contemplating use of cannabis for medical purposes New Health Canada publication also provides evidence-based information to assist healthcare professionals in discussing cannabis use with patients. 1 2 3 4 5 Next Last
